Aaron Dane, MSc

Director
DaneStat Consulting

Disclosure: Da Volterra (Consultant)Spero theraputics (Consultant)

Presentation(s):

• LB-3 - Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study

  Saturday, October 24, 2020
  10:10am – 10:20am EDT

• LB-5 - DAV132 Protects Intestinal Microbiota of Patients Treated with Quinolones, a European Phase II Randomized Controlled Trial (SHIELD)

  Saturday, October 24, 2020
  10:30am – 10:40am EDT